ONCORE™
ONCORE™ Technology (Oral KI Optimization).
Conventional Kinase Inhibitors (KIs) often suffer from low and unpredictable GI absorption. ONCORE™ resolves these issues using a proprietary novel salt formulation:
Enhanced Bioavailability
Improves systemic absorption, allowing for lower therapeutic doses, reduced blood drug concentration fluctuation, and a potential reduction in adverse events (AEs).
1
Reduced pH & PPI Effects
Limits the impact of GI pH variations, meaning medications can be co-administered with acid-reducing agents (PPIs/antacids).
2
Improved Safety & Compliance
Reduces food-effect risks (such as QT interval prolongation) and allows medication to be taken with food, greatly improving patient compliance.
3